High Tower Advisors, LLC Omeros Corp Transaction History

High Tower Advisors, LLC

$71.6 Billion
Q4 2024

A detailed history of High Tower Advisors, LLC transactions in Omeros Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 59,339 shares of OMER stock, worth $417,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,339

Previous 59,339 -0.0%

Holding current value

$417,746

Previous $235,000 149.36%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.54 - $5.47 $14,160 - $21,880	4,000 Added 7.23%	59,339 $235,000
Q1 2024 May 06, 2024	SELL	$2.88 - $4.89 $2,880 - $4,890	-1,000 Reduced 1.77%	55,339 $190,000
Q4 2023 Feb 12, 2024	SELL	$1.08 - $3.63 $14,040 - $47,190	-13,000 Reduced 18.75%	56,339 $184,000
Q3 2023 Nov 08, 2023	BUY	$2.81 - $5.69 $11,240 - $22,760	4,000 Added 6.12%	69,339 $202,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $7.57 $31,150 - $52,990	7,000 Added 12.0%	65,339 $355,000
Q1 2023 May 11, 2023	BUY	$2.48 - $5.22 $14,880 - $31,320	6,000 Added 11.46%	58,339 $271,000
Q4 2022 Feb 08, 2023	SELL	$1.75 - $3.96 $787 - $1,782	-450 Reduced 0.85%	52,339 $118,000
Q3 2022 Nov 09, 2022	BUY	$3.09 - $7.46 $19,158 - $46,252	6,200 Added 13.31%	52,789 $167,000
Q2 2022 Aug 10, 2022	BUY	$1.92 - $6.28 $18,240 - $59,660	9,500 Added 25.61%	46,589 $129,000
Q1 2022 May 12, 2022	BUY	$5.07 - $7.2 $7,478 - $10,620	1,475 Added 4.14%	37,089 $223,000
Q4 2021 Feb 10, 2022	BUY	$5.67 - $8.54 $7,371 - $11,101	1,300 Added 3.79%	35,614 $228,000
Q3 2021 Nov 12, 2021	BUY	$13.4 - $16.3 $26,800 - $32,600	2,000 Added 6.19%	34,314 $472,000
Q2 2021 Aug 06, 2021	SELL	$14.81 - $19.13 $1,377 - $1,779	-93 Reduced 0.29%	32,314 $481,000
Q1 2021 May 10, 2021	SELL	$14.52 - $23.53 $7,986 - $12,941	-550 Reduced 1.67%	32,407 $578,000
Q4 2020 Feb 10, 2021	SELL	$10.14 - $15.19 $588 - $881	-58 Reduced 0.18%	32,957 $471,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $28,710 - $63,960	3,000 Added 10.0%	33,015 $334,000
Q2 2020 Aug 10, 2020	BUY	$12.21 - $16.99 $23,809 - $33,130	1,950 Added 6.95%	30,015 $442,000
Q1 2020 May 21, 2020	BUY	$9.03 - $19.72 $20,778 - $45,375	2,301 Added 8.93%	28,065 $375,000
Q4 2019 Feb 14, 2020	BUY	$13.01 - $17.15 $26,020 - $34,300	2,000 Added 8.42%	25,764 $363,000
Q3 2019 Nov 12, 2019	BUY	$14.55 - $20.56 $125,130 - $176,816	8,600 Added 56.71%	23,764 $388,000
Q2 2019 Aug 13, 2019	SELL	$15.0 - $19.62 $18,750 - $24,525	-1,250 Reduced 7.62%	15,164 $237,000
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $1,072 - $1,673	-100 Reduced 0.61%	16,414 $183,000
Q3 2018 Nov 09, 2018	SELL	$17.73 - $26.69 $15,957 - $24,021	-900 Reduced 5.17%	16,514 $403,000
Q2 2018 Aug 14, 2018	SELL	$10.79 - $24.44 $4,855 - $10,998	-450 Reduced 2.52%	17,414 $316,000
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $1,350 - $3,024	-150 Reduced 0.83%	17,864 $200,000
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $3,885 - $6,697	293 Added 1.65%	18,014 $348,000
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $6,520 - $8,217	330 Added 1.9%	17,721 $384,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,391	17,391 $346,000

Others Institutions Holding OMER

# of Institutions

142

Shares Held

26.9M

Call Options Held

959K

Put Options Held

732K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $442M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Omeros Corp Transaction History